ACRS - Aclaris Therapeutics Stock Trading

Aclaris Therapeutics Inc.(NASDAQ: ACRS) stock trading, description, contact, officers and directors.

About Aclaris Therapeutics Inc.

Aclaris Therapeutics, Inc. is a clinical stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in dermatology

Stock Information

Aclaris Therapeutics Inc. Company Name:

ACRS Stock Symbol:

NASDAQ Market:

Aclaris Therapeutics Inc. Website:

ACRS - Aclaris Therapeutics Stock Trading

ACRS ACRS Quote ACRS Short ACRS News ACRS Articles ACRS Message Board

Get ACRS Alerts

News, Short Squeeze, Breakout and More Instantly...

ACRS - Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021

WAYNE, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will particip...
ACRS - This Could Massively Disrupt the $24.35 Billion NSAID Market

As the standard first-line treatment for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and general pain reduction, naproxen and other NSAIDs are effective, but can induce ulceration and bleeding of the digestive tract, with much higher incidence in patients, as noted by An...
ACRS - Aclaris Therapeutics Announces Positive Preliminary Topline Data from Phase 2a Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis

ATI-1777 Achieved Statistically Significant Result in the Primary Efficacy Endpoint at Week 4 Minimal Systemic Exposure Supports “Soft” Topical JAK Inhibitor Approach ATI-1777 was Generally Well Tolerated Data Support Progression to Ph...